Biotech · Private company
XyloCor Therapeutics, Inc.
Track this companyFree. Adds XyloCor Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- AdVEGFXC1Phase 2 · Coronary Artery DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Sham (No Treatment)Phase 2 · Refractory AnginaClinicalTrials.gov · fetched Nov 12, 2026
- XC001Phase 2 · Coronary Artery Disease (CAD)ClinicalTrials.gov · fetched Nov 12, 2026
- XC001Phase 2 · Refractory AnginaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABGPHASE2 · NOT_YET_RECRUITING · started Aug 27, 2025ClinicalTrials.gov NCT07118449 · fetched Nov 12, 2026
- Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.PHASE2 · RECRUITING · started Jul 8, 2025ClinicalTrials.gov NCT07048808 · fetched Nov 12, 2026
- Epicardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment (The EXACT Trial)PHASE1_PHASE2 · COMPLETED · started Jan 24, 2020ClinicalTrials.gov NCT04125732 · fetched Nov 12, 2026